Education and Inspiration at Inova’s First Melanoma Patient Symposium

Sekwon Jang, MD, is board certified in medical oncology, hematology and internal medicine. He serves as Inova’s director of Melanoma and Cutaneous Oncology Therapeutics and Research at the Inova Schar Cancer Institute. He has a special interest in melanoma and other skin cancers. Read Dr. Jang’s profile.

 On May 21, we held the first-ever Melanoma Patient Symposium. The event was co-sponsored by the Inova Schar Cancer Institute, the Inova Health Foundation and Life With Cancer, a patient support program that serves patients throughout the Inova Health System.

Our goal for the symposium was to educate patients and their families. My co-presenters and I talked about genetic and environmental risk factors, information about the relationship between moles and melanoma and the state of our current therapies for the disease. We also answered patients’ questions about the importance of a healthy diet and what their family members need to know about their melanoma risk.

Another purpose of the symposium was to bring together patients who are being treated for melanoma, both at Inova and elsewhere in the community. This was a great opportunity for patients to connect with and learn from others who are going through a similar experience.

A Team-Based Approach for Exceptional Care

The event was a wonderful chance for our medical team to interact with patients outside of a clinical setting. Patients had many chances to ask questions about everything from healthy diet and sunscreen recommendations to the science behind new immunotherapy treatments.

The symposium brought together expert speakers from a variety of specialties. That was no accident. In fact, it’s reflective of our team-based approach to caring for patients with melanoma. As the region’s only multi-specialty melanoma and oncology program, the Inova Melanoma and Skin Cancer Center brings together treatment teams of dermatologists, surgeons, oncologists, genetic counselors and nurse practitioners. That means better, more coordinated care for patients.

Stories of Hope and Courage

More than 60 patients attended the symposium to learn about melanoma risk factors, treatment options, survivor care and the latest in melanoma research. Their comments after the event highlighted its success:

“Each speaker brought an integral part to this seminar, and each was informative in his/her respective area…and each brought hope to the forefront. Their stories give people both hope & courage.”

 “I am so impressed with Inova…I found that the oncology staff in all areas offers so much of themselves to their patients.”

 “Everything was fabulous. Being able to speak with the doctors and professionals was extremely helpful and encouraging. Meeting other survivors and caregivers was inspirational.”

We hope that the symposium will become a regular event. In the meantime, we invite you to learn more about skin cancer and the Inova Melanoma and Skin Cancer Center.

 

Sekwon Jang

Share
Published by
Sekwon Jang

Recent Posts

Your top vaccine questions: which immunizations do you need?

Christina Baselga, MD is a primary care physician at Inova 360° Concierge Medicine. A board-certified…

5 days ago

Inova introduces precise diagnostic technology for microvascular disease and vasospasm

Inova Schar Heart and Vascular is continuing to build upon its legacy of innovation in…

1 week ago

The most important heart disease risk test you’ve never heard of

What is hsCRP, and how can it help predict your risk of developing heart disease?…

2 weeks ago

Inova continues to set the national standard for excellence in health care

Recognition from U.S. News & World Report, Modern Healthcare and Press Ganey highlights Inova's commitment…

3 weeks ago

Inova appoints Susan Carroll as Chief, Clinical Enterprise Operations   

Raj Chand, MD, to serve as Interim President, Inova Loudoun Hospital  Fairfax, VA — Inova is pleased to announce…

3 weeks ago

Inova first in Virginia and Mid-Atlantic to use advanced fluorescent imaging technology to improve ovarian cancer surgery

FDA-approved technology helps surgeons visualize ovarian cancer in real time during surgery FAIRFAX, Va. –…

4 weeks ago